Literature DB >> 16257194

Effect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiency.

Simon Gompertz1, Adam T Hill, Darren L Bayley, Robert A Stockley.   

Abstract

It is unclear how chronic expectoration influences airway inflammation in patients with chronic lung disease. The aim of this study was to investigate factors influencing inflammation in induced sputum samples, including, in particular, chronic sputum production. Myeloperoxidase, interleukin-8, leukotriene B4 (LTB4), neutrophil elastase, secretory leukoprotease inhibitor (SLPI) and protein leakage were compared in induced sputum samples from 48 patients (36 with chronic expectoration) with COPD (with and without alpha-1-antitrypsin deficiency; AATD), 9 individuals with AATD but without lung disease and 14 healthy controls. There were no differences in inflammation in induced sputum samples from healthy control subjects and from AATD deficient patients with normal lung function but without chronic expectoration (P>0.05). Inflammation in induced sputum from AATD patients with airflow obstruction and chronic sputum expectoration was significantly greater than for similar patients who did not expectorate: Interleukin-8 (P<0.01), elastase activity (P=0.01), and protein leakage (P<0.01). The presence of spontaneous sputum expectoration in AATD patients with airflow obstruction was associated with increased neutrophilic airway inflammation in induced sputum samples. The presence of chronic expectoration in some patients will clearly complicate interpretation of studies employing sputum induction where this feature has not been identified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257194     DOI: 10.1016/j.rmed.2005.09.024

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency.

Authors:  Daniel J Smith; Paul R Ellis; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

2.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

3.  Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Timothy Ramsay; Chun Zhang; Zafrira Avnur; Tania Nikolcheva; Anthony Quinn
Journal:  Respir Res       Date:  2010-04-22

4.  Patterns and characterization of COPD exacerbations using real-time data collection.

Authors:  Stanley I Ejiofor; Jan Stolk; Pablo Fernandez; Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-25

5.  Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.

Authors:  Bruno Balbi; Claudia Sangiorgi; Isabella Gnemmi; Ilaria Ferrarotti; Davide Vallese; Elena Paracchini; Lorena Delle Donne; Luciano Corda; Paolo Baderna; Angelo Corsico; Mauro Carone; Paola Brun; Francesco Cappello; Fabio Lm Ricciardolo; Paolo Ruggeri; Sharon Mumby; Ian M Adcock; Gaetano Caramori; Antonino Di Stefano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-21

6.  Sputum myeloperoxidase in chronic obstructive pulmonary disease.

Authors:  Alling Zhu; Dehai Ge; Jingying Zhang; Yue Teng; Cheng Yuan; Mao Huang; Ian M Adcock; Peter J Barnes; Xin Yao
Journal:  Eur J Med Res       Date:  2014-03-03       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.